Page last updated: 2024-10-17

bupropion and Alzheimer Disease

bupropion has been researched along with Alzheimer Disease in 2 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Maier, F1
Spottke, A1
Bach, JP1
Bartels, C1
Buerger, K1
Dodel, R1
Fellgiebel, A1
Fliessbach, K1
Frölich, L1
Hausner, L1
Hellmich, M1
Klöppel, S1
Klostermann, A1
Kornhuber, J1
Laske, C1
Peters, O1
Priller, J1
Richter-Schmidinger, T1
Schneider, A1
Shah-Hosseini, K1
Teipel, S1
von Arnim, CAF1
Wiltfang, J1
Jessen, F1
Ahn, BJ1
Kwon, KY1

Trials

1 trial available for bupropion and Alzheimer Disease

ArticleYear
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
    JAMA network open, 2020, 05-01, Volume: 3, Issue:5

    Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Apathy; Bupropion; Double-Blind M

2020

Other Studies

1 other study available for bupropion and Alzheimer Disease

ArticleYear
Elderly woman presenting with unusual propriospinal myoclonus triggered by drug-induced nausea and vomiting.
    Geriatrics & gerontology international, 2018, Volume: 18, Issue:3

    Topics: Aged, 80 and over; Alzheimer Disease; Bupropion; Dopamine Agents; Dopamine Uptake Inhibitors; Female

2018